Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 17th August 2023

This is our AI Daily Roundup . We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI)Machine Learning, Robotic Process Automation, Fintech, and human-system interactions. We cover the role of AI Daily Roundup and its application in various industries and daily lives.

CareValidate Unveils AskJanet: Your Personalized AI Concierge for ADA Accommodations

CareValidate, a leading innovator in the field of accessibility technology, is thrilled to announce the launch of their revolutionary generative AI platform, AskJanet. This groundbreaking platform is poised to transform the way employees and employers start and move through the ADA accommodations process.

ConcertAI’s TeraRecon Partners with GLEAMER to Advance Clinical AI Capabilities on the Eureka Clinical AI Platform

Advanced visualization and AI leader TeraRecon, a ConcertAI company, is proud to announce its strategic partnership with GLEAMER, a leading provider of AI solutions for medical imaging. By joining forces, the two companies aim to advance the field of radiology by integrating GLEAMER’s BoneView and ChestView solutions into TeraRecon’s Eureka Clinical AI Platform.

Digitalatto Ltd Launches IDO Phase 2, Ushering in a New Era of Innovative DApps and an AI Chatbot Platform for Online Businesses

Digitalatto Ltd UK, a trailblazing force in the blockchain ecosystem, is thrilled to announce the highly anticipated launch of IDO Phase 2 for its groundbreaking cryptocurrency, DGTL. Building on the immense success of the initial phase, IDO Phase 2 propels DGTL into an era of unparalleled innovation, solidifying its pioneering role in the realm of loyalty solutions powered by blockchain technology and Artificial Intelligence.

Related Posts
1 of 41,053

Voiceflow Announces $15 Million Investment from OpenView Venture Partners

Voiceflow, the industry’s first and leading collaboration platform for building AI agents, announced it has closed a $15 million round of financing led by OpenView, a leading venture capital firm focused on business software. With this latest investment round, Voiceflow will amplify its commitment to product innovation while helping conversational AI product teams design, test, and launch AI agents for customer support.

Zenhub Brings AI to Project Management for Software Development Teams

Zenhub, the leading project management platform for software teams, announced its product roadmap for incorporating Artificial Intelligence (AI) into its award-winning project management solution. Zenhub’s approach to leveraging AI aims to simplify the day-to-day processes and operational overhead involved in software project management, which can often get in the way of shipping code faster. Zenhub AI focuses on the team rather than the individual, serving as a co-pilot to assist in all the ancillary activities to writing code, such as managing projects and tasks, categorizing and prioritizing work, and other productivity-related activities.

Parexel and Partex Announce Innovative Alliance Leveraging Artificial Intelligence and Big Data to Accelerate Drug Discovery and Development

Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, and Partex, the first Data-to-Drugs pharma platform, announced a preferred strategic alliance designed to leverage artificial intelligence (AI)-powered solutions to accelerate drug discovery and development for biopharmaceutical customers worldwide and de-risk the assets in their portfolios.

 [To share your insights with us, please write to sghosh@martechseries.com] 

Comments are closed.